Vela Diagnostics Inc. test kits
Closed Solicitation Posted
- Solicitation number
- HCWBB-2024-00236
- Agency
- CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Atlanta, Georgia 30329, United States
- Points of contact
-
- Cletus Schafrath ztb8@cdc.gov (770) 488-5475
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Vela Diagnostics, Inc. for test kits for the Sentosa SQ HIV-1 Genotyping Assay. This assay is an automated system that carries out the entire lab process from sample to result report, including viral extraction, RT-PCR, library preparation, next generation sequencing, data analysis, and HIV drug resistance reporting. Vela Diagnostics is the only company that manufactures these FDA-approved test kits. The government is soliciting and negotiating with only one source under the authority of FAR 13.106-1(b) and 41 U.S.C. 3304(a)(1). Interested parties may identify their interest and capability to respond, and any quotations/responses received within three days will be considered.
There is no set-aside designation for this procurement. Vela Diagnostics is the incumbent and the sole manufacturer of the required test kits. The government has not specified an award value or budget range. The place of performance is Atlanta, GA. The NAICS code is 325414 - Biological Product (except Diagnostic) Manufacturing, and the PSC code is 6640-P - Laboratory Equipment And Supplies.
Notice text
The Centers for Disease Control (CDC) and Prevention intends to award a sole source firm fixed price purchase order to Vela Diagnostics, Inc. for test kits for the Sentosa SQ HIV-1 Genotyping Assay, which is an automation method, carrying out whole lab procedures from sample to result report, including HIV viral extraction, RT-PCR, library preparation, next generation sequencing, data analysis, and next generation sequencing (NGS) HIV drug resistance (HIVDR) reports. Vela Dianotistics, Inc. is the only company that manufactures these test kits that are FDA approved. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1).. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is NOT a request for competitive quotations; however, all quotations/responses received within three (3) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at ZTB8@cdc.gov by COB 29 August 2024.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity